ORACLE CORP SEC Filing

An Oracle insider filed a notice of proposed stock sales under Rule 144, covering up to 35,000 shares of common stock.

Accepted by SEC EDGAR 01/15/2026 - 09:35 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

An Oracle insider filed a notice of proposed stock sales under Rule 144, covering up to 35,000 shares of common stock. The shares are to be sold through Fidelity Brokerage Services on or about 01/15/2026 on the NYSE, with an aggregate market value of $6,821,150.00 based on the figures provided. Oracle had 2,873,130,000 shares of common stock outstanding, giving context for the relative size of this planned sale.

The shares listed for sale were recently acquired through restricted stock vesting from the issuer, including 3,539 shares vested on 09/19/2025 and 31,461 shares vested on 09/20/2025 as compensation. By signing the notice, the selling party represents that they are not aware of any undisclosed material adverse information about Oracle’s current or prospective operations.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ORCL disclose?

The filing discloses that an Oracle insider plans to sell up to 35,000 shares of Oracle common stock under Rule 144, using Fidelity Brokerage Services as broker and listing the NYSE as the exchange.

How many Oracle (ORCL) shares are planned for sale and what is their value?

The notice covers up to 35,000 Oracle common shares with an aggregate market value of approximately $6,821,150.00, based on the figures in the filing.

When are the planned Oracle (ORCL) share sales expected to occur?

The approximate date of sale listed is 01/15/2026, with the trades expected to take place on the NYSE through Fidelity Brokerage Services LLC.

How were the Oracle (ORCL) shares in this Form 144 acquired?

The shares were acquired through restricted stock vesting from the issuer as compensation, including 3,539 shares on 09/19/2025 and 31,461 shares on 09/20/2025.

How large is the planned Oracle (ORCL) sale relative to shares outstanding?

Oracle had 2,873,130,000 common shares outstanding according to the filing; the planned sale of 35,000 shares is described against this baseline figure.

What representation does the seller make in the Oracle (ORCL) Form 144?

By signing the notice, the seller represents that they do not know any material adverse information about Oracle’s current or prospective operations that has not been publicly disclosed.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001527283
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ORACLE CORP
SEC File Number	001-35992
Address of Issuer	2300 ORACLE WAY AUSTIN TEXAS 78741
Phone	(737) 867-1000
Name of Person for Whose Account the Securities are To Be Sold	KEHRING DOUGLAS A
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	35000	6821150.00	2873130000	01/15/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/19/2025	Restricted Stock Vesting	Issuer			3539	09/19/2025	Compensation
Common	09/20/2025	Restricted Stock Vesting	Issuer			31461	09/20/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	01/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	10/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Douglas Kehring
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)